Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 1, 2010, Pages 246-253

  Kim, Sang Soo ^a,b   Park, Min Sun ^a   Cho, Seung Woo ^a   Kang, Sun Woong ^a   Ahn, Kang Min ^c   Lee, Jong Ho ^d   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Ulsan College of Medicine   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Angiogenesis; Bone marrow cells; Bone regeneration; Cell transplantation; Endothelial cells; Tissue engineering

Indexed keywords

ANGIOGENESIS; BONE FORMATION; BONE MARROW; BONE MARROW CELLS; BONE REGENERATION; BONE TISSUE; CALVARIAL DEFECTS; CELL DELIVERY; CELL TRANSPLANTATION; HISTOLOGICAL ANALYSIS; HYDROXYAPATITE COMPOSITE; IN-VIVO; MICROCOMPUTED TOMOGRAPHY; MINERALIZED BONE; OSSEOUS DEFECTS; OSTEOGENIC CELLS; POLY LACTIDE-CO-GLYCOLIDE; SOFT X-RAY;

APATITE; BLOOD VESSEL PROSTHESES; COMPUTERIZED TOMOGRAPHY; CYTOLOGY; DEFECTS; ENDOTHELIAL CELLS; HYDROXYAPATITE; PHOSPHATE MINERALS; SELF ASSEMBLY; TISSUE ENGINEERING;

BONE;

APATITE; HYDROXYAPATITE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE REGENERATION; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DOGS; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOGENESIS; X-RAY MICROTOMOGRAPHY;

EID: 73549124797     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32360     Document Type: Article

References (32)

1. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712.
2. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003;8:980-989.
3. Stahl A, Wu X, Wenger A, Klagsbrun M, Kurschat P. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: A model for bone replacement grafts. FEBS Lett 2005;579:5338-5342.
4. Ennett AB, Mooney DJ. Tissue engineering strategies for in vivo neovascularisation. Expert Opin Biol Ther 2002;2:805-818.
5. Kaigler D, Krebsbach PH, Wang Z, West ER, Horger K, Mooney DJ. Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 2006;85:633-637.
6. Derubeis AR, Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: Limitations and recent advances. Ann Biomed Eng 2004;32:160-165.
7. Bianco P, Robey PG. Marrow stromal stem cells. J Clin Invest 2000;105:1663-1668.
8. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, Yoo KJ, Park HY, Jang Y, Chang BC, Choi CY, Hwang KC, Kim BS. Small-diameter blood vessels engineered with bone marrowderived cells. Ann Surg 2005;241:506-515.
9. Kaigler D, Krebsbach PH, West ER, Horger K, Huang YC, Mooney DJ. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 2005;19:665-667.
10. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
11. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
12. Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963.
13. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386.
14. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-134.
15. Kim SS, Lim SH, Hong YS, Cho SW, Ryu JH, Chang BC, Choi CY, Kim BS. Tissue engineering of heart valves in vivo using bone marrow-derived cells. Artif Organs 2006;30:554-557.
16. Kim SS, Lim SH, Cho SW, Gwak SJ, Hong YS, Chang BC, Park MH, Song KW, Choi CY, Kim BS. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells. Exp Mol Med 2006;38:273-283.
17. Ahn SE, Kim S, Park KH, Moon SH, Lee HJ, Kim GJ, Lee YJ, Park KH, Cha KY, Chung HM. Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun 2006;340:403-408.
18. Kalra M, Jost CJ, Severson SR, Miller VM. Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein grafts with endothelial nitric oxide synthase gene. J Vasc Surg 2000;32:1190-1200.
19. Murata M, Kador PF, Sato S. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocul Pharmacol Ther 2000;16:383-391.
20. Volk SW, Diefenderfer DL, Christopher SA, Haskins ME, Leboy PS. Effects of osteogenic inducers on cultures of canine mesenchymal stem cells. Am J Vet Res 2005;66:1729-1737.
21. Ishida A, Wu MH, Shi Q, Fujita Y, Sauvage LR, Hammond WP, Wijelath ES. Dynamic changes of smooth muscle and endothelial markers in the early healing process of dacron vascular grafts in the dog, using RT-PCR. Int J Angiol 2000;9:107-110.
22. Kim SS, Park MS, Jeon O, Choi CY, Kim BS. Poly(lactide-coglycolide)/ hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006;27:1399-1409.
23. Kim SS, Park MS, Gwak SJ, Choi CY, Kim BS. Accelerated bone-like apatite growth on porous polymer/ceramic composite scaffolds in vitro. Tissue Eng 2006;12:2997-3006.
24. Aalami OO, Nacamuli RP, Lenton KA, Cowan CM, Fang TD, Fong KD, Shi YY, Song HM, Sahar DE, Longaker MT. Applications of a mouse model of calvarial healing: differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg 2004;114:713-720.
25. Kim SS, Ahn KM, Park MS, Lee LH, Choi CY, Kim BS. A poly (lactide-co-glycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed Mater Res A 2007;80:206-215.
26. Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y. Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 1998;19:807-815.
27. Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, Amedee J. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 2002;282:C775-C785.
28. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing. Plast Reconstr Surg 2002;109:2384-2397.
29. Wang DS, Miura M, Demura H, Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997;138:2953-2962.
30. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: Clinical experience. Biomaterials 2003;24:2303-2308.
31. Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, Katoh M, Ishiguro N. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-A preliminary result of three cases. Bone 2004;35:892-898.
32. Park MS, Kim SS, Cho SW, Choi CY, Kim BS. Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor. J Biomed Mater Res B Appl Biomater 2006;79:353-359.